Stem Cells
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


First published online September 22, 2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2005-0017v1
24/3/671    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arbab, A. S.
Right arrow Articles by Frank, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arbab, A. S.
Right arrow Articles by Frank, J. A.
Submitted on January 12, 2005
Accepted on September 12, 2005

Original Article

MRI and Confocal Microscopy Studies of Magnetically Labeled Endothelial Progenitor Cells Trafficking to Sites of Tumor Angiogenesis

Ali S. Arbab 1, Sunil D. Pandit 2, Stasia A. Anderson 2, Gene T. Yocum 2, Monica Bur 2, Hanh M. Khuu 2, Elizabeth J. Read 2, Joseph A. Frank 2*

1 Henry Ford Health System, Detroit, Michigan
2 National Institutes of Health, Bethesda, Maryland

* To whom correspondence should be addressed. E-mail: jafrank{at}helix.nih.gov.


   Abstract

Purpose: AC133 cells, a subpopulation of CD34+ hematopoietic stem cells, can transform into endothelial cells that may integrate into the neovasculature of tumors or ischemic tissue. Most current imaging modalities do not allow monitoring of early migration and incorporation of endothelial progenitor cells (EPCs) into tumor neovasculature. The goals of this study were to use MRI to track the migration and incorporation of intravenously injected, magnetically labeled EPCs into the blood vessels in a rapidly growing flank tumor model, to determine if the pattern of EPC incorporation is related to the time of injection or tumor size. Experimental Design: EPCs labeled with ferumoxides-protamine sulfate (FePro) complexes were injected into mice bearing xenografted glioma, and MRI was obtained at different stages of tumor development and size. Results: Migration and incorporation of labeled EPCs into tumor neovasculature were detected as low signal intensity on MRI at the tumor periphery as early as 3 days after EPC administration in preformed tumors. However, low signal intensities were not observed in tumors implanted at the time of EPC administration until tumor size reached 1 cm, at 12-14 days. Prussian blue staining showed iron positive cells at the sites corresponding to low signal intensity on MRI. Confocal microcopy showed incorporation into the neovasculature and immunohistochemistry clearly demonstrated the transformation of the administered EPCs into endothelial cells. Conclusion: In conclusion, MRI demonstrated the incorporation of FePro labeled human CD34+/AC133+ EPCs into the neovasculature of implanted flank tumors.

Key Words. Ferumoxides, Protamine Sulfate, Neovasculature, Quantum dots, Stem Cells, Magnetic Resonance Imaging, Vasculogenesis




This article has been cited by other articles:


Home page
FASEB J.Home page
A. S. Arbab, B. Janic, R. A. Knight, S. A. Anderson, E. Pawelczyk, A. M. Rad, E. J. Read, S. D. Pandit, and J. A. Frank
Detection of migration of locally implanted AC133+ stem cells by cellular magnetic resonance imaging with histological findings
FASEB J, September 1, 2008; 22(9): 3234 - 3246.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
E. Pawelczyk, A. S. Arbab, A. Chaudhry, A. Balakumaran, P. G. Robey, and J. A. Frank
In Vitro Model of Bromodeoxyuridine or Iron Oxide Nanoparticle Uptake by Activated Macrophages from Labeled Stem Cells: Implications for Cellular Therapy
Stem Cells, May 1, 2008; 26(5): 1366 - 1375.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
Z. Li, Y. Suzuki, M. Huang, F. Cao, X. Xie, A. J. Connolly, P. C. Yang, and J. C. Wu
Comparison of Reporter Gene and Iron Particle Labeling for Tracking Fate of Human Embryonic Stem Cells and Differentiated Endothelial Cells in Living Subjects
Stem Cells, April 1, 2008; 26(4): 864 - 873.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
M. Neri, C. Maderna, C. Cavazzin, V. Deidda-Vigoriti, L. S. Politi, G. Scotti, P. Marzola, A. Sbarbati, A. L. Vescovi, and A. Gritti
Efficient In Vitro Labeling of Human Neural Precursor Cells with Superparamagnetic Iron Oxide Particles: Relevance for In Vivo Cell Tracking
Stem Cells, February 1, 2008; 26(2): 505 - 516.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Granot, Y. Addadi, V. Kalchenko, A. Harmelin, L. A. Kunz-Schughart, and M. Neeman
In vivo Imaging of the Systemic Recruitment of Fibroblasts to the Angiogenic Rim of Ovarian Carcinoma Tumors
Cancer Res., October 1, 2007; 67(19): 9180 - 9189.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. Yu, X. Sun, Y. Qiu, J. Zhou, Y. Wu, L. Zhuang, J. Chen, and Y. Ding
Identification and Clinical Significance of Mobilized Endothelial Progenitor Cells in Tumor Vasculogenesis of Hepatocellular Carcinoma
Clin. Cancer Res., July 1, 2007; 13(13): 3814 - 3824.
[Abstract] [Full Text] [PDF]


Home page
Plant Physiol.Home page
Y. Paz, E. Shimoni, M. Weiss, and U. Pick
Effects of Iron Deficiency on Iron Binding and Internalization into Acidic Vacuoles in Dunaliella salina
Plant Physiology, July 1, 2007; 144(3): 1407 - 1415.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
K. C. Partlow, J. Chen, J. A. Brant, A. M. Neubauer, T. E. Meyerrose, M. H. Creer, J. A. Nolta, S. D. Caruthers, G. M. Lanza, and S. A. Wickline
19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons
FASEB J, June 1, 2007; 21(8): 1647 - 1654.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H.-K. Oh, J.-M. Ha, E. O, B. H. Lee, S. K. Lee, B.-S. Shim, Y.-K. Hong, and Y. A. Joe
Tumor Angiogenesis Promoted by Ex vivo Differentiated Endothelial Progenitor Cells Is Effectively Inhibited by an Angiogenesis Inhibitor, TK1-2
Cancer Res., May 15, 2007; 67(10): 4851 - 4859.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. L. Tejada, L. Yu, J. Dong, K. Jung, G. Meng, F. V. Peale, G. D. Frantz, L. Hall, X. Liang, H.-P. Gerber, et al.
Tumor-Driven Paracrine Platelet-Derived Growth Factor Receptor {alpha} Signaling Is a Key Determinant of Stromal Cell Recruitment in a Model of Human Lung Carcinoma.
Clin. Cancer Res., May 1, 2006; 12(9): 2676 - 2688.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS

Copyright © 2005 by AlphaMed Press.